Walgreens Boots Alliance Inc WBA shares continue to trade lower Friday after the company on Thursday reported financial results and reaffirmed soft guidance for low-single digit earnings growth.
Walgreens said fiscal second-quarter revenue increased 3% year-over-year to $33.8 billion, which beat the $33.36 billion estimate. The company reported quarterly earnings of $1.59 per share, which beat the estimate of $1.38 per share.
Walgreens maintained its previously-issued earnings guidance, expecting low-single digit growth in fiscal-year 2022.
Analyst Assessment: Multiple analysts lowered price targets on the stock following Walgreens' results.
- RBC Capital analyst Ben Hendrix maintained Walgreens with a Sector Perform rating and lowered the price target from $52 to $46.
- Barclays analyst Steve Valiquette maintained Walgreens with an Equal-Weight rating and lowered the price target from $54 to $50.
- Truist Securities analyst David Macdonald maintained Walgreens with a Hold rating and lowered the price target from $58 to $50.
Related Link: Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022
WBA 52-Week Range: $43.62 - $57.05
The stock was down 2.47% at $43.68 at time of publication.
Photo: courtesy of Walgreens.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.